Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

about

Therapeutic Approaches to Atrophic Vaginitis in Postmenopausal Women: A Systematic Review with a Network Meta-analysis of Randomized Controlled Trials.

P2860

Q55432577-C44DA4E1-9AB5-4BCB-AA39-95A33065D2E7

P2860

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

Item

http://www.wikidata.org/entity/Q41689276

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

@en

type

Item

label

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

@en

prefLabel

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

@en

P1476

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

@en

P2093

Chang Suk Suh

http://www.w3.org/2001/XMLSchema#string

Jae Jun Shin

http://www.w3.org/2001/XMLSchema#string

Jung Ryeol Lee

http://www.w3.org/2001/XMLSchema#string

Seul Ki Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.

Rejuvenation Using Platelet-rich Plasma and Lipofilling for Vaginal Atrophy and Lichen Sclerosus.

Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.

Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.

Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.

Ospemifene use in postmenopausal women.

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.

P304

79-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6118/JMM.2017.23.2.79

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28951854

http://www.w3.org/2001/XMLSchema#string

P932

5606913

http://www.w3.org/2001/XMLSchema#string

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

about

P2860

P2860

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932